Transglutaminase 2 regulates terminal erythroid differentiation via cross-linking activity

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Transglutaminase 2 (TGM2) is a versatile enzyme that modulates cell survival and differentiation. However, its role in terminal erythroid differentiation is poorly understood. In this study, we investigated the function of TGM2 in primary fetal liver erythroid differentiation. We predicted TGM2 as an upstream regulator via ingenuity pathway analysis (IPA), and found that its expression was increased at both RNA and protein level during terminal erythroid differentiation. TGM2 cross-linking activity inhibitors GK921 and Z-DON suppressed erythroid maturation and enucleation, while its GTPase inhibitor LDN27219 had no such effect. Z-DON treatment arrested differentiation at basophilic erythroblast stage, and interfered with cell cycle progression. RT-PCR demonstrated decreased GATA-1 and KLF1, and disarranged cyclin, CDKI and E2F family genes expression after Z-DON treatment. In conclusion, TGM2 regulates terminal erythroid differentiation through its cross-linking enzyme activity.

Cite

CITATION STYLE

APA

Zhang, Y., Shi, L., Yang, K., Liu, X., & Lv, X. (2023). Transglutaminase 2 regulates terminal erythroid differentiation via cross-linking activity. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1183176

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free